Target-  | 
Mechanism-  | 
 | 
 | 
 | 
Inactive Indication-  | 
Drug Highest PhaseApproved  | 
First Approval Ctry. / Loc.China   | 
First Approval Date27 Apr 2020  | 
Target-  | 
Mechanism-  | 
 | 
 | 
 | 
Inactive Indication-  | 
Drug Highest PhaseApproved  | 
First Approval Ctry. / Loc.China   | 
First Approval Date24 Apr 2020  | 
100 Clinical Results associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.
0  Patents (Medical) associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.
100 Deals associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.
100 Translational Medicine associated with Tianjin Darentang No. 2 Pharmaceutical Factory Co. Ltd.